COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | COM | 00287Y109 | 821,016 | 14,373,538 | SH | | SOLE | | 14,373,538 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 677,019 | 24,213,838 | SH | | SOLE | | 24,213,838 | 0 | 0 |
Acceleron Pharma, Inc. | COM | 00434H108 | 759 | 28,765 | SH | | SOLE | | 28,765 | 0 | 0 |
Achaogen, Inc. | COM | 004449104 | 276 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 19,111 | 2,475,515 | SH | | SOLE | | 2,475,515 | 0 | 0 |
Acorda Therapeutics, Inc. | COM | 00484M106 | 96,836 | 3,661,082 | SH | | SOLE | | 3,661,082 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 2,496 | 172,630 | SH | | SOLE | | 172,630 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 813 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | 21,538 | 615,033 | SH | | SOLE | | 1,230,066 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 3,640 | 299,356 | SH | | SOLE | | 299,356 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 1,496 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 12,501 | 307,915 | SH | | SOLE | | 307,915 | 0 | 0 |
Aimmune Therapeutics, Inc. | COM | 00900T107 | 3,390 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Akari Therapeutics plc | SPONSORED ADR | 00972G108 | 5,542 | 395,882 | SH | | SOLE | | 395,882 | 0 | 0 |
Alcobra Ltd. | SHS | M2239P109 | 8,855 | 2,336,359 | SH | | SOLE | | 2,336,359 | 0 | 0 |
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 595 | 142,000 | SH | | SOLE | | 142,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 910,861 | 6,542,599 | SH | | SOLE | | 6,542,599 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 8,556 | 250,251 | SH | | SOLE | | 250,251 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 712 | 11,340 | SH | | SOLE | | 11,340 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 1,227 | 801,860 | SH | | SOLE | | 801,860 | 0 | 0 |
Anacor Pharmaceuticals, Inc. | COM | 032420101 | 273,791 | 5,122,375 | SH | | SOLE | | 5,122,375 | 0 | 0 |
Aptose Biosciences Inc. | COM NEW | 03835T200 | 100 | 33,397 | SH | | SOLE | | 33,397 | 0 | 0 |
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 68,377 | 7,752,487 | SH | | SOLE | | 7,752,487 | 0 | 0 |
Array BioPharma Inc. | COM | 04269X105 | 12,716 | 4,310,666 | SH | | SOLE | | 4,310,666 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | COM NEW | 04280A100 | 4,866 | 1,009,509 | SH | | SOLE | | 1,009,509 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 9,377 | 505,521 | SH | | SOLE | | 505,521 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 1,255 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
aTyr Pharma, Inc. | COM | 002120103 | 8,422 | 2,137,606 | SH | | SOLE | | 2,137,606 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 2,082 | 711,499 | SH | | SOLE | | 711,499 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 56,061 | 1,912,680 | SH | | SOLE | | 24,864,840 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 45,494 | 4,865,647 | SH | | SOLE | | 4,865,647 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 42,480 | 15,010,534 | SH | | SOLE | | 15,010,534 | 0 | 0 |
BioDelivery Sciences International, Inc. | COM | 09060J106 | 678 | 210,021 | SH | | SOLE | | 210,021 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 396,439 | 4,806,483 | SH | | SOLE | | 4,806,483 | 0 | 0 |
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 12 | 20,084 | SH | | SOLE | | 20,084 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 15,000 | 352,943 | SH | | SOLE | | 352,943 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 6,433 | 5,498,459 | SH | | SOLE | | 5,498,459 | 0 | 0 |
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,375 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 80,371 | 13,553,275 | SH | | SOLE | | 13,553,275 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 122 | 49,064 | SH | | SOLE | | 49,064 | 0 | 0 |
Chimerix, Inc. | COM | 16934W106 | 589 | 115,216 | SH | | SOLE | | 115,216 | 0 | 0 |
Concert Pharmaceuticals, Inc. | COM | 206022105 | 6,774 | 495,908 | SH | | SOLE | | 495,908 | 0 | 0 |
Curis, Inc. | COM | 231269101 | 3,219 | 1,999,303 | SH | | SOLE | | 1,999,303 | 0 | 0 |
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 76 | 13,253 | SH | | SOLE | | 13,253 | 0 | 0 |
CytRx Corporation | COM PAR $.001 | 232828509 | 1,769 | 659,995 | SH | | SOLE | | 659,995 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 179,336 | 5,509,560 | SH | | SOLE | | 2,754,780 | 0 | 0 |
Derma Sciences, Inc. | COM PAR $.01 | 249827502 | 11,632 | 3,752,390 | SH | | SOLE | | 3,752,390 | 0 | 0 |
Dermira, Inc. | COM | 24983L104 | 5,687 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Dimension Therapeutics, Inc. | COM | 25433V105 | 9,802 | 1,251,881 | SH | | SOLE | | 1,251,881 | 0 | 0 |
Discovery Laboratories, Inc. | COM PAR | 254668502 | 426 | 254,973 | SH | | SOLE | | 254,973 | 0 | 0 |
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,443 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Enanta Pharmaceuticals, Inc. | COM | 29251M106 | 2,213 | 75,357 | SH | | SOLE | | 75,357 | 0 | 0 |
Endocyte, Inc. | COM | 29269A102 | 5,257 | 1,695,865 | SH | | SOLE | | 1,695,865 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 2,818 | 232,481 | SH | | SOLE | | 232,481 | 0 | 0 |
Exelixis, Inc. | COM | 30161Q104 | 10,320 | 2,580,000 | SH | | SOLE | | 2,580,000 | 0 | 0 |
Five Prime Therapeutics, Inc. | COM | 33830X104 | 782 | 19,247 | SH | | SOLE | | 19,247 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 14,616 | 2,241,702 | SH | | SOLE | | 2,241,702 | 0 | 0 |
Foundation Medicine, Inc. | COM | 350465100 | 380 | 20,892 | SH | | SOLE | | 20,892 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 12,688 | 303,394 | SH | | SOLE | | 303,394 | 0 | 0 |
Genomic Health, Inc. | COM | 37244C101 | 338,354 | 13,659,832 | SH | | SOLE | | 13,659,832 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 9,516 | 600,000 | SH | | SOLE | | 600,000 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 1,082 | 15,000 | SH | | SOLE | | 15,000 | 0 | 0 |
Halozyme Therapeutics, Inc. | COM | 40637H109 | 18,287 | 1,931,057 | SH | | SOLE | | 1,931,057 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 55,219 | 2,907,784 | SH | | SOLE | | 2,907,784 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 13,841 | 6,990,189 | SH | | SOLE | | 6,990,189 | 0 | 0 |
Ignyta, Inc. | COM | 451731103 | 3,866 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Immune Design Corp. | COM | 45252L103 | 1,936 | 148,937 | SH | | SOLE | | 148,937 | 0 | 0 |
ImmunoGen, Inc. | COM | 45253H101 | 37,935 | 4,452,445 | SH | | SOLE | | 4,452,445 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 1,702,933 | 23,498,460 | SH | | SOLE | | 23,498,460 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 19,005 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 16,935 | 609,166 | SH | | SOLE | | 609,166 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 67,057 | 6,554,967 | SH | | SOLE | | 6,554,967 | 0 | 0 |
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 2,792 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Ironwood Pharmaceuticals, Inc. | COM CL A | 46333X108 | 1,851 | 169,163 | SH | | SOLE | | 169,163 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | COM | 462222100 | 2,314 | 57,140 | SH | | SOLE | | 57,140 | 0 | 0 |
Juno Therapeutics, Inc. | COM | 48205A109 | 3,047 | 80,000 | SH | | SOLE | | 80,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | COM | 48576U106 | 1,936 | 216,990 | SH | | SOLE | | 216,990 | 0 | 0 |
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 287 | 13,746 | SH | | SOLE | | 13,746 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 7,859 | 73,386 | SH | | SOLE | | 73,386 | 0 | 0 |
Lion Biotechnologies, Inc. | COM | 53619R102 | 5,417 | 1,066,285 | SH | | SOLE | | 1,066,285 | 0 | 0 |
Loxo Oncology, Inc. | COM | 548862101 | 3,766 | 137,735 | SH | | SOLE | | 137,735 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 6,819 | 363,676 | SH | | SOLE | | 363,676 | 0 | 0 |
Mast Therapeutics, Inc. | COM | 576314108 | 1,309 | 4,797,442 | SH | | SOLE | | 4,797,442 | 0 | 0 |
Medivation, Inc. | COM | 58501N101 | 15,168 | 329,876 | SH | | SOLE | | 329,876 | 0 | 0 |
Medgenics Inc. | COM NEW | 58436Q203 | 3,366 | 765,000 | SH | | SOLE | | 765,000 | 0 | 0 |
MediWound Ltd. | ORD SHS | M68830104 | 1,824 | 226,000 | SH | | SOLE | | 226,000 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 69,947 | 3,268,556 | SH | | SOLE | | 3,268,556 | 0 | 0 |
Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | 3,136 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
Natera, Inc. | COM | 632307104 | 4,284 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 35,414 | 895,422 | SH | | SOLE | | 895,422 | 0 | 0 |
NeuroDerm Ltd. | ORD SHS | M74231107 | 4,307 | 305,000 | SH | | SOLE | | 305,000 | 0 | 0 |
Novavax, Inc. | COM | 670002104 | 12,277 | 2,379,254 | SH | | SOLE | | 2,379,254 | 0 | 0 |
Omeros Corporation | COM | 682143102 | 11,493 | 749,250 | SH | | SOLE | | 749,250 | 0 | 0 |
Ophthotech Corporation | COM | 683745103 | 1,507 | 35,649 | SH | | SOLE | | 35,649 | 0 | 0 |
Osiris Therapeutics, Inc. | COM | 68827R108 | 2,850 | 499,193 | SH | | SOLE | | 499,193 | 0 | 0 |
Palatin Technologies, Inc. | COM PAR $.01 | 696077403 | 1,107 | 2,050,000 | SH | | SOLE | | 2,050,000 | 0 | 0 |
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 18,970 | 4,350,808 | SH | | SOLE | | 4,350,808 | 0 | 0 |
ProNai Therapeutics, Inc. | COM | 74346L101 | 1,348 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
ProQR Therapeutics N.V. | SHS EURO | N71542109 | 6,587 | 1,349,719 | SH | | SOLE | | 1,349,719 | 0 | 0 |
Proteon Therapeutics Inc. | COM | 74371L109 | 2,311 | 298,591 | SH | | SOLE | | 298,591 | 0 | 0 |
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 452 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Sage Therapeutics, Inc. | COM | 78667J108 | 7,183 | 224,048 | SH | | SOLE | | 224,048 | 0 | 0 |
Sangamo BioSciences, Inc. | COM | 800677106 | 24,538 | 4,055,876 | SH | | SOLE | | 4,055,876 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 1,517,126 | 43,235,267 | SH | | SOLE | | 43,235,267 | 0 | 0 |
Seres Therapeutics, Inc. | COM | 81750R102 | 3,320 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Spark Therapeutics, Inc. | COM | 84652J103 | 37,253 | 1,262,382 | SH | | SOLE | | 1,262,382 | 0 | 0 |
Stemline Therapeutics, Inc. | COM | 85858C107 | 1,554 | 333,497 | SH | | SOLE | | 333,497 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM NEW | 867328601 | 2,403 | 4,450,000 | SH | | SOLE | | 4,450,000 | 0 | 0 |
Arbutus Biopharma Corporation | COM | 03879J100 | 746 | 180,582 | SH | | SOLE | | 180,582 | 0 | 0 |
Tenax Therapeutics, Inc. | COM | 88032L100 | 861 | 420,000 | SH | | SOLE | | 420,000 | 0 | 0 |
TG Therapeutics, Inc. | COM | 88322Q108 | 17,074 | 2,003,991 | SH | | SOLE | | 2,003,991 | 0 | 0 |
Trevena, Inc. | COM | 89532E109 | 3,722 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 1,959 | 211,792 | SH | | SOLE | | 211,792 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 7,844 | 123,894 | SH | | SOLE | | 123,894 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 2,732 | 230,000 | SH | | SOLE | | 230,000 | 0 | 0 |
Versartis, Inc. | COM | 92529L102 | 25,660 | 3,199,559 | SH | | SOLE | | 3,199,559 | 0 | 0 |
Vitae Pharmaceuticals, Inc. | COM | 92847N103 | 4,227 | 637,597 | SH | | SOLE | | 637,597 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 11,703 | 872,072 | SH | | SOLE | | 872,072 | 0 | 0 |
XenoPort, Inc. | COM | 98411C100 | 15,675 | 3,475,672 | SH | | SOLE | | 3,475,672 | 0 | 0 |
Zogenix, Inc. | COM NEW | 98978L204 | 9,240 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | 68,456 | 77,083,000 | PRN | | SOLE | | 77,083,000 | 0 | 0 |
Anacor Pharmaceuticals Inc. 2.0% 15 OCT 2021 | NOTE 2.0% 10/15/2021 | 032420AC5 | 75,337 | 42,000,000 | PRN | | SOLE | | 42,000,000 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | NOTE 2.0% 8/15/2019 | 00767EAB8 | 13,526 | 26,517,000 | PRN | | SOLE | | 26,517,000 | 0 | 0 |
Array BioPharma Inc. Notes 3.0% 6/1/2020 | NOTE 3.0% 6/1/2020 | 04269XAA3 | 2,382 | 3,000,000 | PRN | | SOLE | | 3,000,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | 89,825 | 22,379,000 | PRN | | SOLE | | 22,379,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | NOTE 0.75% 10/15/2018 | 09061GAE1 | 14,125 | 12,228,000 | PRN | | SOLE | | 12,228,000 | 0 | 0 |
Clovis Oncology Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | 87,801 | 129,300,000 | PRN | | SOLE | | 129,300,000 | 0 | 0 |
Corsicanto Ltd. 3.5% 1/15/2032 | NOTE 3.5% 1/15/2032 | 220480AB3 | 12,103 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
Exelixis, Inc. Notes 4.25% 8/15/2019 | NOTE 4.25% 8/15/2019 | 30161QAC8 | 19,775 | 20,000,000 | PRN | | SOLE | | 20,000,000 | 0 | 0 |
Gilead Sciences, Inc. 1.625% 5/1/16 | NOTE 1.625% 5/1/2016 | 375558AP8 | 85,863 | 20,944,000 | PRN | | SOLE | | 20,944,000 | 0 | 0 |
Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | 397,943 | 259,000,000 | PRN | | SOLE | | 259,000,000 | 0 | 0 |
Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | 432,150 | 274,500,000 | PRN | | SOLE | | 274,500,000 | 0 | 0 |
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,334 | 3,423,000 | PRN | | SOLE | | 3,423,000 | 0 | 0 |
Xenoport, Inc. Notes 2.5% 2/1/2022 | NOTE 2.5% 2/1/2022 | 98411CAB6 | 73,436 | 100,000,000 | PRN | | SOLE | | 100,000,000 | 0 | 0 |